肠道微生物尿液活性驱动高氨血症,并预测肝硬化症的开放性肝脑病变
Deepika Jakhar1, Saggere M Shasthry2, Guresh Kumar2
1Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi 110070, India.
Journal of clinical and experimental hepatology
|November 24, 2025
概括
便尿素酶活性 (SUA) 在肝硬化中升高,预测明显的肝脑病变 (OHE). 肠道微生物尿酶的增加有助于高氨血症,使得SUA成为肝硬化患者OHE发展的潜在生物标志物.
科学领域:
- 胃肠病学和肝病学
- 微生物学 微生物学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 超血是明显肝脑病变 (OHE) 的发展和预后的核心.
- 氨在肠道中由细菌尿酶产生,并由肝脏清除.
- 肠道微生物尿酶活性在氨代谢和OHE中的作用需要进一步研究.
研究的目的:
- 研究肠道微生物尿酶活性,氨代谢和肝硬化中的OHE之间的关系.
- 评估便尿酶活性 (SUA) 作为肝硬化患者新发性OHE的预测因子.
主要方法:
- 实验性大鼠肝硬化模型被用来研究氨代谢和SUA.
- 给大鼠采用尿素酶阳性细菌 (Klebsiella pneumoniae) 进行测量,以评估其对SUA和氨水平的影响.
- 基线SUA和血氨在肝硬化患者和健康对照人群中测量,随访3个月,监测OHE的发展.
主要成果:
- 与对照组相比,肝硬化老鼠的SUA和血氨量显著增加.
- 使用Klebsiella pneumoniae的Gavage在肝硬化老鼠中增加了SUA和氨水平.
- 肝硬化患者的SUA和血氨量高于对照组;SUA比血氨量更好地预测OHE.
结论:
- 肠尿酶活性直接导致肝硬化时血氨水平升高.
- 增加便尿酶活性 (SUA) 是预测肝硬化患者新发明显肝脑病变的有希望的生物标志物.
相关概念视频
Urea Cycle
49.5K
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
49.5K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
170
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
170
Hepatic Drug Excretion: Enterohepatic Cycling
2.6K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
2.6K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
204
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
204
Amino Acid Catabolism
954
Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
954
Serum Laboratory Studies, Stool Test, Breath Test
735
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
735


